XML 42 R29.htm IDEA: XBRL DOCUMENT v3.19.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
 3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Schedule of error corrections and prior period adjustments
The following table presents the effect of the revisions on the Company’s Consolidated Balance Sheet as of March 31, 2018:
(in millions)
As Previously Reported
 
Adjustment
 
As Revised
Deferred tax liabilities, net
$
1,139

 
$
(112
)
 
$
1,027

Total liabilities
31,275

 
(112
)
 
31,163

Accumulated deficit
(4,209
)
 
112

 
(4,097
)
Total Bausch Health Companies Inc. shareholders' equity
4,424

 
112

 
4,536

Total equity
4,523

 
112

 
4,635

The following table presents the effect of the revisions on the Company’s Consolidated Statements of Operations and Comprehensive Loss for the three months ended March 31, 2018:
(in millions, except per share amounts)
As Previously Reported
 
Adjustment
 
As Revised
Consolidated Statement of Operations
 
 
 
 
 
Benefit from income taxes
$
(3
)
 
$
(112
)
 
$
(115
)
Net loss
(2,691
)
 
112

 
(2,579
)
Net loss attributable to Bausch Health Companies Inc.
(2,693
)
 
112

 
(2,581
)
Basic and diluted loss per share attributable to Bausch Health Companies Inc.
(7.68
)
 
0.32

 
(7.36
)
Consolidated Statement of Comprehensive Loss
 
 
 
 
 
Foreign currency translation adjustment
(46
)
 
92

 
46

Other comprehensive (loss) income
(46
)
 
92

 
46

Comprehensive loss
(2,737
)
 
204

 
(2,533
)
Comprehensive loss (income) attributable to noncontrolling interest
2

 
(6
)
 
(4
)
Comprehensive loss attributable to Bausch Health Companies Inc.
(2,735
)
 
198

 
(2,537
)